SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-190873
Filing Date
2022-07-11
Accepted
2022-07-11 07:00:59
Documents
16
Period of Report
2022-07-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d356984d8k.htm   iXBRL 8-K 26318
2 EX-99.1 d356984dex991.htm EX-99.1 22244
6 GRAPHIC g356984g0710203650162.jpg GRAPHIC 2285
7 GRAPHIC g356984g0710203650396.jpg GRAPHIC 24481
8 GRAPHIC g356984g0710203650553.jpg GRAPHIC 11487
  Complete submission text file 0001193125-22-190873.txt   228057

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA plrx-20220710.xsd EX-101.SCH 2861
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE plrx-20220710_lab.xml EX-101.LAB 17237
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plrx-20220710_pre.xml EX-101.PRE 10816
10 EXTRACTED XBRL INSTANCE DOCUMENT d356984d8k_htm.xml XML 3245
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Filer) CIK: 0001746473 (see all company filings)

IRS No.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39303 | Film No.: 221075863
SIC: 2834 Pharmaceutical Preparations